Literature DB >> 10538884

A review of the use of health status measures in economic evaluation.

J Brazier1, M Deverill, C Green.   

Abstract

OBJECTIVE: To review the use of measures of health status in the assessment of benefits in economic evaluation, whether or not the measures were designed for this purpose.
METHODS: The review was based on a systematic search of the literature. It provides a comprehensive assessment of the evidence where it exists and a balanced overview of opinion otherwise.
RESULTS: Over 3000 papers were identified, of which 632 were found to be relevant. The review provides a set of recommendations. These include: a checklist of questions for selecting a measure for use in economic evaluation; a list of circumstances in which non-preference-based measures can be used; and recommendations surrounding the use of health state valuation techniques and multi-attribute utility scales.
CONCLUSION: These recommendations should help to identify poor economic evaluations and hence guard against inefficient conclusions being drawn regarding the provision of health services.

Mesh:

Year:  1999        PMID: 10538884     DOI: 10.1177/135581969900400310

Source DB:  PubMed          Journal:  J Health Serv Res Policy        ISSN: 1355-8196


  33 in total

1.  Comparison of hypothetical and experienced EQ-5D valuations: relative weights of the five dimensions.

Authors:  Kim Rand-Hendriksen; Liv Ariane Augestad; Ivar Sønbø Kristiansen; Knut Stavem
Journal:  Qual Life Res       Date:  2011-09-20       Impact factor: 4.147

2.  A Norwegian 15D value algorithm: proposing a new procedure to estimate 15D value algorithms.

Authors:  Yvonne Anne Michel; Liv Ariane Augestad; Mathias Barra; Kim Rand
Journal:  Qual Life Res       Date:  2018-11-30       Impact factor: 4.147

3.  Evaluating the conduct and application of health utility studies: a review of critical appraisal tools and reporting checklists.

Authors:  Michael J Zoratti; A Simon Pickard; Peep F M Stalmeier; Daniel Ollendorf; Andrew Lloyd; Kelvin K W Chan; Don Husereau; John E Brazier; Murray Krahn; Mitchell Levine; Lehana Thabane; Feng Xie
Journal:  Eur J Health Econ       Date:  2021-04-11

Review 4.  Model-based cost-effectiveness analyses for the treatment of chronic lymphocytic leukaemia: a review of methods to model disease outcomes and estimate utility.

Authors:  Kevin Marsh; Peng Xu; Panagiotis Orfanos; James Gordon; Ingolf Griebsch
Journal:  Pharmacoeconomics       Date:  2014-10       Impact factor: 4.981

5.  Validation and comparison of 15-D and EQ-5D-5L instruments in a Spanish Parkinson's disease population sample.

Authors:  Miguel Ángel García-Gordillo; Borja del Pozo-Cruz; José Carmelo Adsuar; Fernando Ignacio Sánchez-Martínez; José María Abellán-Perpiñán
Journal:  Qual Life Res       Date:  2013-11-22       Impact factor: 4.147

6.  Individualized chiropractic and integrative care for low back pain: the design of a randomized clinical trial using a mixed-methods approach.

Authors:  Kristine K Westrom; Michele J Maiers; Roni L Evans; Gert Bronfort
Journal:  Trials       Date:  2010-03-08       Impact factor: 2.279

7.  Integrative care for the management of low back pain: use of a clinical care pathway.

Authors:  Michele J Maiers; Kristine K Westrom; Claire G Legendre; Gert Bronfort
Journal:  BMC Health Serv Res       Date:  2010-10-29       Impact factor: 2.655

8.  Alternative approaches to derive disability weights in injuries: do they make a difference?

Authors:  Juanita A Haagsma; S Polinder; E F van Beeck; S Mulder; G J Bonsel
Journal:  Qual Life Res       Date:  2009-05-07       Impact factor: 4.147

9.  Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B.

Authors:  Y X Jia; F Q Cui; L Li; D L Zhang; G M Zhang; F Z Wang; X H Gong; H Zheng; Z H Wu; N Miao; X J Sun; L Zhang; J J Lv; F Yang
Journal:  Qual Life Res       Date:  2014-03-14       Impact factor: 4.147

10.  Disability adjusted life years and minimal disease: application of a preference-based relevance criterion to rank enteric pathogens.

Authors:  Juanita A Haagsma; Arie H Havelaar; Bas Mf Janssen; Gouke J Bonsel
Journal:  Popul Health Metr       Date:  2008-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.